Market Size of Self-Expanding Stents Industry
Study Period | 2021 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 7.50 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Self-Expanding Stents Market Analysis
The self-expanding stents market is expected to register a CAGR of 7.5% over the forecast period.
The COVID-19 outbreak has had a huge influence on people's lives across the world. Only true emergencies, such as acute aortic dissections, were attended to during the peak, with all elective surgeries being postponed and patients being prioritized surgically. For instance, as per an article published in a European heat journal in October 2021, there was a reduction of 27.5% in admissions of acute coronary syndromes compared to 2019. Additionally, according to a research study published in March 2022, titled "The Effect of COVID-19 on Adult Cardiac Surgery in the United States in 717,103 Patients", it was concluded that there was a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases, which indicates the negative impact of COVID-19 on the cardiac surgical procedures. However, the market started to gain traction owing to the resumption of surgical procedures worldwide. According to Eurostat, nearly 38,900 heart bypasses were conducted in Germany in 2020. The number of cardiac surgical procedures and stent implantations is projected to grow during the forecast period, positively impacting the market's growth.
The major factors propelling the growth of the self-expandable stents market include the high prevalence of heart-related diseases, advancement in healthcare technology, and increased demand for angioplasty.
Additionally, major market players' product launches and strategic activities positively affect the studied market's growth. For instance, in September 2022, Wallaby/phenox launched the Pegasus HPC stent system. It enables more patients to benefit from surface modification in stent-assisted coiling treatments, intracranial atherosclerotic disease (ICAD), and dissections. Applying this surface modification to the stent enhances safety by significantly reducing thrombogenic complications; the device addresses multiple indications while providing all the benefits of classic laser-cut, open-cell stents and adding increased patient safety.
Moreover, the worldwide advancement in healthcare technology is driving the demand for effective and advanced treatment services that involve various stent procedures. For instance, in April 2020, an article published in the national library of medicine, recent advances in manufacturing innovative stents shows aiming for greater patient safety and a higher success rate for cardiovascular treatments, researchers and doctors are focusing heavily on developing novel materials, methods, and solutions to improve the clinical outcome of currently available stent types. Therefore, owing to the abovementioned factors, the studied market is anticipated to witness growth over the analysis period.
Self-Expanding Stents Industry Segmentation
As per the scope of the report, self-expanding stents are mechanical self-expanding stents that are devices composed of stainless steel; it depends on a mechanical "springlike" construction when compressed within a delivery catheter to produce expansion. Most stents are constructed from metal or plastic mesh. The self-expanding stents market is expected to register a CAGR of 7.50% over the forecast period. Self-expanding stents market is segmented by Product type (Gastrointestinal Self-expanding Stents, Carotid Self-expanding Stents, Endovascular Self-expandable Stents, and Others), Application (Fem-Pop Artery, Iliac Artery, Carotid Artery, Biliary, and Others), End-users (Hospitals, Ambulatory Surgical Centers, and Others) and Geography (North America, Europe, Asia-pacific, middle east, and Africa, and South America). The report offers the value (in USD million) for the above segment.
By Product Type | |
Carotid Self-expanding Stents | |
Gastrointestinal Self-expanding Stents | |
Endovascular Self-expandable Stents | |
Others |
By Application | |
Fem-Pop Artery | |
Iliac Artery | |
Carotid Artery | |
Biliary | |
Other |
By End-User | |
Hospitals | |
Ambulatory Surgical Centers | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Self-Expanding Stents Market Size Summary
The self-expanding stents market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases and advancements in healthcare technology. The market is recovering from the disruptions caused by the COVID-19 pandemic, which had led to a substantial reduction in elective cardiac procedures. As surgical activities resume globally, the demand for self-expanding stents is expected to rise, supported by the introduction of innovative products and strategic initiatives by key market players. These developments are enhancing the safety and efficacy of stent procedures, thereby boosting market expansion. The carotid self-expanding stents segment, in particular, is anticipated to experience robust growth due to the rising incidence of cardiovascular conditions and ongoing technological advancements.
North America is projected to lead the self-expanding stents market, attributed to the presence of major industry players and a strong focus on minimally invasive procedures. The region's market growth is further supported by new product launches and strategic collaborations aimed at maintaining competitive advantage. Companies are actively engaging in mergers and acquisitions to strengthen their market positions, as evidenced by significant transactions such as Boston Scientific's acquisition of M.I. Tech. The market is characterized by a mix of emerging and established players, with key companies like Medtronic, Boston Scientific, and Abbott driving innovation and expansion. These factors collectively contribute to the anticipated growth of the self-expanding stents market over the forecast period.
Self-Expanding Stents Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 High Prevalence of Heart-Related Diseases
-
1.2.2 Advancement in Healthcare Technology
-
1.2.3 Increase in Demand for Angioplasty
-
-
1.3 Market Restraints
-
1.3.1 Availability of Alternative Treatment and Rising Product Recalls
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Carotid Self-expanding Stents
-
2.1.2 Gastrointestinal Self-expanding Stents
-
2.1.3 Endovascular Self-expandable Stents
-
2.1.4 Others
-
-
2.2 By Application
-
2.2.1 Fem-Pop Artery
-
2.2.2 Iliac Artery
-
2.2.3 Carotid Artery
-
2.2.4 Biliary
-
2.2.5 Other
-
-
2.3 By End-User
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
2.3.3 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Self-Expanding Stents Market Size FAQs
What is the current Self-Expanding Stents Market size?
The Self-Expanding Stents Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Self-Expanding Stents Market?
Medtronic, BD Interventional, Boston Scientific, Abbott and Cook Medical are the major companies operating in the Self-Expanding Stents Market.